RESULTS	During a mean follow-up of 15 + / - 3 months , two of six ( 33 % ) patients in group A and three of seven ( 43 % ) patients in group B relapsed with HBV-DNA and HBeAg positivity , which meant an overall sustained response of 40 % and 28 % , respectively .\